L-TIL
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for L-TIL, covering 2024-05-23 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy [Phase 2]